Screener
Altimmune ALT Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$0.12Beat by $0.02
Revenue estimate$2.0K
EPS estimate-$0.14
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.8K
EPS estimate-$0.14
Versus estimates
FAQ
- When did Altimmune report Q2 2026 earnings?
- Altimmune (ALT) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Altimmune's Q2 2026 revenue and EPS?
- Altimmune reported eps of $-0.12 for Q2 2026.
- Did Altimmune beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.14 by $0.02.
- How did Altimmune's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 55.6% from $-0.27.
- Where can I find Altimmune's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001326190-26-000049) and the 10-Q periodic report (0001326190-26-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.
